Your browser doesn't support javascript.
loading
Improved Survival Prediction by Combining Radiological Imaging and S-100B Levels Into a Multivariate Model in Metastatic Melanoma Patients Treated With Immune Checkpoint Inhibition.
Burgermeister, Simon; Gabrys, Hubert S; Basler, Lucas; Hogan, Sabrina A; Pavic, Matea; Bogowicz, Marta; Martínez Gómez, Julia M; Vuong, Diem; Tanadini-Lang, Stephanie; Foerster, Robert; Huellner, Martin W; Dummer, Reinhard; Levesque, Mitchell P; Guckenberger, Matthias.
Afiliação
  • Burgermeister S; Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Gabrys HS; Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Basler L; Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Hogan SA; Department of Dermatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Pavic M; Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Bogowicz M; Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Martínez Gómez JM; Department of Dermatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Vuong D; Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Tanadini-Lang S; Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Foerster R; Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Huellner MW; Department of Nuclear Medicine, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Dummer R; Department of Dermatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Levesque MP; Department of Dermatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Guckenberger M; Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Front Oncol ; 12: 830627, 2022.
Article em En | MEDLINE | ID: mdl-35494048
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article